Evidence map›Paper›PMID 35808130›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Controlled Synthesis of Platinum and Silver Nanoparticles Using Multivalent Ligands.

Suguna Perumal, Raji Atchudan, Eckart Rühl, Christina Graf

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suguna PerumalPhysikalische Chemie, Institut für Chemie und Biochemie, Freie Universität Berlin, 14195 Berlin, Germany.ORCID 0000-0002-4637-736X
Raji AtchudanSchool of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Korea.ORCID 0000-0001-8793-0953
Eckart RühlPhysikalische Chemie, Institut für Chemie und Biochemie, Freie Universität Berlin, 14195 Berlin, Germany.ORCID 0000-0002-0451-8734
Christina GrafPhysikalische Chemie, Institut für Chemie und Biochemie, Freie Universität Berlin, 14195 Berlin, Germany.ORCID 0000-0002-3308-5640

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, the controlled formation of platinum nanoparticles (PtNPs) and silver nanoparticles (AgNPs) using amine-functionalized multivalent ligands are reported. The effects of reaction temperature and ligand multivalency on the growth kinetics, size, and shape of PtNPs and AgNPs were systematically studied by performing a stepwise and a one-step process. PtNPs and AgNPs were prepared in the presence of amine ligands using platinum (II) acetylacetonate and silver (I) acetylacetonate, respectively. The effects of ligands and temperature on the formation of PtNPs were studied using a transmission electron microscope (TEM). For the characterization of AgNPs, additionally, ultraviolet-visible (UV-Vis) absorption was employed. The TEM measurements revealed that PtNPs prepared at different temperatures (160-200 °C, in a stepwise process) are monodispersed and of spherical shape regardless of the ligand multivalency or reaction temperature. In the preparation of PtNPs by the one-step process, ligands affect the shape of the PtNPs, which can be explained by the affinity of the ligands. The TEM and UV-Vis absorption studies on the formation of AgNPs with mono-, di-, and trivalent ligands showed narrower size distributions, while increasing the temperature from 80 °C to 120 °C and with a trivalent ligand in a one-step process.

Indexed as

Ag(acac)2digestive ripeningmonodisperse nanoparticlesmultivalent ligandsPt(acac)2size distribution

Identifiers

PMID35808130
PMCPMC9268602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.